Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept With Delayed Tacrolimus Withdrawal Versus Standard-of-Care Tacrolimus in Heart Transplant Recipients
NCT06478017Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2025
- Primary completion
- Jan 2028
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of belatacept in heart transplant rejection, sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2025; status: recruiting.
02
Drugs
belatacept
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT06478017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06478017.